Clinical and economic burden of community-acquired pneumonia in the Veterans Health Administration, 2011: a retrospective cohort study.

John M McLaughlin, Maribeth H Johnson, Stephen A Kagan, Stephanie L Baer
Author Information
  1. John M McLaughlin: Pfizer Vaccines, New York, NY, USA. john.mclaughlin@pfizer.com.
  2. Maribeth H Johnson: Charlie Norwood VA Medical Center, Augusta, GA, USA.
  3. Stephen A Kagan: Pfizer Vaccines, New York, NY, USA.
  4. Stephanie L Baer: Charlie Norwood VA Medical Center, Augusta, GA, USA.

Abstract

PURPOSE: The burden of community-acquired pneumonia (CAP) is not well described in the US Veterans Health Administration (VHA).
METHODS: CAP was defined as having a pneumonia diagnosis with evidence of chest X-ray, and no evidence of prior (90 days) hospitalization/long-term care. We calculated incidence rates of adult CAP occurring in inpatient or outpatient VHA settings in 2011. We also estimated the proportion of VHA CAP patients who were hospitalized, were readmitted within 30 days of hospital discharge, and died (any cause) in the year following diagnosis. Incremental costs during the 90 days following a CAP diagnosis were estimated from the perspective of the VHA.
RESULTS: In 2011, 34,101 Veterans developed CAP (35,380 episodes) over 7,739,757 VHA person-years. Median age of CAP patients was 65 years (95 % male). CAP incidence rates were higher for those aged ≥50 years. A majority of Veterans aged 50-64 (53 %) and ≥65 (66 %) years had ≥1 chronic medical (moderate risk) or immunocompromising (high risk) condition. Compared to those at low-risk (healthy), moderate- and high-risk Veterans were >3 and >6 times more likely to develop CAP, respectively. The percentage of CAP patients who were hospitalized was 45 %, ranging from 12 % (age 18-49, low risk) to 57 % (age ≥65, high risk). One-year all-cause mortality rates ranged from 1 % (age 18-49, low risk) to 36 % (age ≥65, high risk). Annual VHA medical expenditure related to CAP was estimated to be $750 million (M) ($415M for those aged ≥65 years).
CONCLUSION: A focus on CAP prevention among older Veterans and those with comorbid or immunocompromising conditions is important.

Keywords

References

  1. Postgrad Med. 2010 Mar;122(2):130-41 [PMID: 20203464]
  2. Intensive Care Med. 2002 Aug;28(8):1003-5 [PMID: 12398086]
  3. Am Health Drug Benefits. 2013 Sep;6(8):494-503 [PMID: 24991378]
  4. Med Care. 2007 Mar;45(3):214-23 [PMID: 17304078]
  5. Infection. 2013 Oct;41(5):935-9 [PMID: 23709294]
  6. Clin Infect Dis. 2004 Dec 1;39(11):1642-50 [PMID: 15578365]
  7. Arch Intern Med. 2000 Nov 27;160(21):3252-7 [PMID: 11088086]
  8. J Am Geriatr Soc. 2012 Nov;60(11):2137-43 [PMID: 23110409]
  9. Hum Vaccin Immunother. 2015;11(7):1825-7 [PMID: 26076136]
  10. Infection. 2013 Oct;41(5):1005-11 [PMID: 23703286]
  11. Chest. 2004 Jun;125(6):2140-5 [PMID: 15189934]
  12. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416 [PMID: 15699079]
  13. J Am Geriatr Soc. 2006 Feb;54(2):217-23 [PMID: 16460371]
  14. Med Care Res Rev. 2003 Sep;60(3 Suppl):15S-36S [PMID: 15095543]
  15. Med Care. 2011 Oct;49(10):911-7 [PMID: 21685810]
  16. Semin Respir Crit Care Med. 2009 Apr;30(2):179-88 [PMID: 19296418]
  17. Vaccine. 2010 Jul 12;28(31):4955-60 [PMID: 20576535]
  18. Int J Antimicrob Agents. 2011 Aug;38(2):108-17 [PMID: 21683553]
  19. Health Serv Res. 2010 Oct;45(5 Pt 1):1268-86 [PMID: 20831716]
  20. Med Care Res Rev. 2003 Sep;60(3 Suppl):54S-73S [PMID: 15095546]
  21. N Engl J Med. 2015 Mar 19;372(12):1114-25 [PMID: 25785969]
  22. Health Serv Res. 2010 Jun;45(3):762-91 [PMID: 20403056]
  23. Clin Ther. 1998 Jul-Aug;20(4):820-37 [PMID: 9737840]
  24. Am J Med. 1985 Jun 28;78(6B):45-51 [PMID: 4014287]
  25. Infect Dis Clin North Am. 2004 Dec;18(4):761-76, vii [PMID: 15555823]
  26. Arch Intern Med. 1998 Mar 23;158(6):626-32 [PMID: 9521227]
  27. Thorax. 2012 Jan;67(1):71-9 [PMID: 20729232]
  28. Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):33-47 [PMID: 21533875]
  29. MMWR Recomm Rep. 1997 Apr 4;46(RR-8):1-24 [PMID: 9132580]
  30. MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5 [PMID: 25233284]
  31. J Infect Dis. 2005 Aug 1;192(3):377-86 [PMID: 15995950]

MeSH Term

Adolescent
Adult
Aged
Aged, 80 and over
Community-Acquired Infections
Female
Health Care Costs
Hospitalization
Humans
Incidence
Male
Middle Aged
Pneumonia
Retrospective Studies
Survival Analysis
United States
Veterans Health
Young Adult

Word Cloud

Created with Highcharts 10.0.0CAP%VeteransVHAriskagepneumoniayears≥65diagnosisdaysratesestimatedpatientsagedhighburdencommunity-acquiredHealthAdministrationevidence90incidence2011hospitalizedfollowingmedicalimmunocompromising18-49lowRiskPURPOSE:welldescribedUSMETHODS:definedchestX-raypriorhospitalization/long-termcarecalculatedadultoccurringinpatientoutpatientsettingsalsoproportionreadmittedwithin30hospitaldischargediedcauseyearIncrementalcostsperspectiveRESULTS:34101developed35380episodes7739757person-yearsMedian6595malehigher≥50majority50-645366≥1chronicmoderateconditionComparedlow-riskhealthymoderate-high-risk>3>6timeslikelydeveloprespectivelypercentage45ranging1257One-yearall-causemortalityranged136Annualexpenditurerelated$750millionM$415MCONCLUSION:focuspreventionamongoldercomorbidconditionsimportantClinicaleconomic2011:retrospectivecohortstudyBurdendiseaseCommunity-acquiredEpidemiologyfactorstatus

Similar Articles

Cited By